BayBio Notes
1 2 3 4 5 10 20 100 > >>
- Agilent Technologies Announces Cash Dividend of 10 Cents per Share - May 16, 2012
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that a quarterly dividend of 10 cents per share of common stock will be paid on July 25 to all shareholders...
Read More... - DNAnexus names IT veteran as president, COO - May 16, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/blog/biotech/OlesenMarc*100.jpg?v=1'>DNAnexus Inc., a young Mountain View company that has created a way for medical researchers...
Read More... - Avalanche Bio inks manufacturing technology deal with Lonza - May 16, 2012
<img src='http://assets.bizjournals.com/sanfrancisco/print-edition/ChalbergThomas2187_sb11*100.jpg?v=1'>Startup Avalanche Biotechnologies Inc. and biologics manufacturer Lonza Group...
Read More... - BioCision to Present at the International Society for Biological and Environmental Repositories Annual Meeting - May 16, 2012
LARKSPUR, Calif.--(BUSINESS WIRE)--BioCision LLC, a leader in advanced temperature management of biomedical samples, today announced the presentation of data supporting the need for standardization...
Read More... - Rigel moving asthma drug into mid-stage trial - May 16, 2012
Rigel Pharmaceuticals Inc. will move an asthma drug into a Phase II trial. At the American Thoracic Society Conference in San Francisco, Rigel (NASDAQ: RIGL) said enrollment in the 276-patient...
Read More... - DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic “Reader” Proteins - May 16, 2012
FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation today announced the launch of BROMOscanSM, a new service platform for identification and optimization of inhibitors targeting bromodomain...
Read More... - UCSF School of Medicine Celebrates 2012 Commencement - May 16, 2012
The UCSF School of Medicine congratulated students on May 11 for their success in graduating from one of the best medical schools in the country.<div class="feedflare"> <a...
Read More... - DNAnexus Appoints Marc Olesen as President and COO - May 16, 2012
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, a DNA data management and analysis platform, has announced the appointment of Marc Olesen as President and COO.
Read More... - Reminder: Exelixis Announces Data Presentations, Webcast of Investor Briefing in Conjunction With 2012 ASCO Annual Meeting - May 16, 2012
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) reiterated its slate of activities in conjunction with the 2012 American Society of Clinical Oncology (ASCO) Annual...
Read More... - Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System - May 16, 2012
SUNNYVALE, Calif. & PARIS--(BUSINESS WIRE)--Excellent Results from Elixir's DESolve FIM for Bioresorbable Drug Eluting Coronary Scaffold System. Unparalleled data @ PCR: Exceptionally Low...
Read More... - Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies - May 16, 2012
Read More... - Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012 - May 16, 2012
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company will present important new data from studies of...
Read More... - USPTO Grants Codexis Patent for Enzymes Used in Hep-C Therapeutics - May 15, 2012
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (Nasdaq:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates,...
Read More... - Upcoming Life Science Events plus List of Positions through May 14 - May 15, 2012
I’ve listed the meetings for this upcoming week with full details of events through July in Audrey’s Picks. Download by right clicking on title. I’ve also provided this week’s updated...
Read More... - Achaogen Announces All Objectives Met in Phase 2 Plazomicin Complicated Urinary Tract Infections Study and Start of First-in-Human Study with ACHN-975 - May 15, 2012
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Achaogen, Inc. announced today that all objectives were met in the company's multi-national Phase 2 study of plazomicin compared to levofloxacin...
Read More... - KineMed to Discuss New Applications of Biomarkers for Neurodegenerative Therapeutics at the 7th Annual Neurotech Investing & Partnering Conference - May 15, 2012
EMERYVILLE, Calif.--(BUSINESS WIRE)--Biomarkers for drug development in CNS disease and personalized medicine applications to be discussed by KineMed CEO David Fineman at the 7th annual Neurotech...
Read More... - UCSF School of Dentistry Successfully Concludes 2012 Accreditation Process - May 15, 2012
Preliminary conclusions of the American Dental Association's Commission on Dental Accreditation (CODA) tell a positive story about the UCSF School of Dentistry in its 131st year.<div...
Read More... - Malaria Conference Draws Experts Aimed at Eradicating the Disease - May 15, 2012
Malaria might be eliminated from countries it has plagued for centuries, according to malaria experts who gathered for a World Malaria Day symposium on April 25 at the UCSF Mission Bay...
Read More... - IntegenX Names Biotechnology Veteran David V. Smith Chief Operating Officer - May 15, 2012
PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX Inc. today announced the appointment of David V. Smith as Chief Operating Officer.
Read More... - Solazyme to Present at Investor Conferences - May 14, 2012
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company, announced today that the company will be presenting at the following upcoming...
Read More...
